drugset / Trial / NCT01115946

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Enalapril in Healthy Volunteers

NCT01115946

Phase 1 Completed 24 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

This study is to assess the effect of ASP1585 on pharmacokinetics of enalapril in 2x2 crossover method.

Timeline

Start
2010-03
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Bixalomer Small molecule Oral
Subject Enalapril Other / unclassified Oral

Indications

No indication recorded.